Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Januar 2019 09:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

CHARLOTTESVILLE, Va., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for...
15. Januar 2019 09:05 ET | Quelle: Adial Pharmaceuticals, Inc.

Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series

CHARLOTTESVILLE, Va., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of...
10. Januar 2019 10:24 ET | Quelle: Adial Pharmaceuticals, Inc.

Update: Adial Pharmaceuticals to Present at The 2019 Wall Street Conference

CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
10. Januar 2019 08:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals to Present at The 2019 Wall Street Conference

CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
24. Dezember 2018 08:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Retires All Outstanding Debt

CHARLOTTESVILLE, Va., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL;ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
19. Dezember 2018 09:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group

CHARLOTTESVILLE, Va., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
13. Dezember 2018 08:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl

CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
10. Dezember 2018 08:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder

CHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused on the development of...
29. November 2018 09:10 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder

CHARLOTTESVILLE, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
21. November 2018 08:00 ET | Quelle: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Chairman Featured in Doctors Channel Video Discussing Alcohol Use Disorder

CHARLOTTESVILLE, Va., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...

Vorherige Seite

Nächste Seite